3 assets in Ganglioneuroblastoma

Therapeutic assets addressing Ganglioneuroblastoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Ganglioneuroblastoma	Beijing Biotech	P1/2	CCC (48)
Eb-Dtnb-Nk Ganglioneuroblastoma	Beijing Biotech	P1/2	CCC (48)
Fludarabine Ganglioneuroblastoma	Beijing Biotech	P1/2	CCC (48)